The present study was carried out to develop and evaluate mouth dissolving tablets of Tolperisone hydrochloride using superdisintegrants agents namely Crospovidone and Sodium starch glycolate in different ratio. Mouth dissolving tablets are solid dosage form containing medicinal substances which disintegrates rapidly, usually within a matter of seconds, when placed upon the tongue. The mouth dissolving tablets were prepared by direct compression method using Crospovidone and Sodium starch glycolate. Tablets blends were evaluated for loose bulk density, tapped bulk density, compressibility index and angle of repose, shows satisfactory results. The compressed tablets were then evaluated for various physical tests like thickness, friability, hardness, weight variation, wetting time, water absorption ratio and disintegration test by using standard procedures. The results of all these tests were found to be satisfactory. The in-vitro dissolution study was carried out for 14 min using paddle method in phosphate buffer (pH 6.8) as dissolution media. The data of in-vitro dissolution of tablets revealed that 78 to 100% of drug release from various formulations at 14 min.
Introduction
The tablet is the most widely used dosage form because of its convenience in terms of self-administration, compactness, and ease in manufacturing. For the past one decade, there has been an enhanced demand for more patient-friendly and compliant dosage forms 1 . However, this form of dosage has some limitation like motion sickness, sudden episodes of allergic attacks or coughing and unavailability of water, but one important drawback is 'dysphagia' or difficulty in swallowing. Particularly, the difficulty is experienced by paediatric and geriatric patients in swallowing conventional tablets, which lead to poor patient compliance [2] [3] [4] .
Mouth dissolving tablets have gained considerable attention as a preferred alternative to conventional tablets and capsules due to better patient compliance.
Tolperisone hydrochloride is a centrally acting muscle relaxant having half life of 1.5 to 2.5 h, bioavailability of 20% and more stable in acidic than basic media with high solubility in water. It is recently prescribed by physician for the treatment of back pain, arthrosis of large joints (degeneration of cartilage tissue in joints), spastic muscle cramps, paralysis, and muscle pain. Tolperisone hydrochloride has a short elimination half-life; it is rapidly and completely absorbed from the gastrointestinal tract. Conventional
Tolperisone tablet available in the market are not suitable for acute pain and inflammatory conditions where quick onset of action of drug is required. The rapidly disintegrating tablets in oral cavity can be swallowed with a small amount of water or saliva [5] [6] [7] . Hence, an attempt was made to improve the dissolution of Tolperisone through the formulation of mouth-dissolving tablets with appropriate mechanical strength, which would disintegrate in oral cavity, in less than 30 seconds, and would provide an immediate relief from pain due to its faster dissolution in gastrointestinal tract.
Materials and Methods

Materials
Tolperisone was obtained from Aristo Pharma Ltd. Baddi (H.P.).
Crospovidone and sodium starch glycolate were obtained as gift samples from Micro Labs, Bangalore.
Methods
Preparation of mouth dissolving tablets
Tablets of Tolperisone were prepared by direct compression method. All the formulation ingredients mentioned in formulation table 1 were weighed accordingly and mixed in a mortar and pestle. This powder blend was then allowed to dry for few moments and then again mixed well and passed through sieve no 60. Then blend were used for further processing. [8] [9] [10] Powder blend prepared were evaluated for various rheological properties like bulk density, tapped density, Hausner's ratio, angle of repose by using standard procedures. All these properties were carried out in triplicate (n=3) and average values were reported.
Evaluation of pre-compression characteristics of powder blend
Bulk density
Bulk density was determined by placing the powders blend in a measuring cylinder and the total volume is noted. The weight of powder bed was determined by using digital weighing balance.
Bulk density was calculated using the following formula:
Bulk Density = Weight of the powder / Volume of the powder 
Tapped density
Hausner's ratio
It is expressed in percentage and is expressed by
H=D t /D b
Where D t is the tapped density of the powder D b is the bulk density of the powder. [11] [12] [13] [14] The prepared tablets were evaluated for their thickness, friability, hardness, weight variation and dissolution test by using standard procedures.
Evaluation of compression characteristics of mouth dissolving tablets
Weight variation test
20 tablets are taken and their weight is determined individually and collectively on a digital weighting balance. The average weight of one tablet is determined from the collective weight. Note more than 2 of the individual weights may deviate from the average weight by more than the percentage deviation given in the monographs and none should deviate by more than twice that percentage given in the monographs.
Thickness test
The tablets were evaluated for their thickness using a venirer caliper measured in terms of micrometer. Averages of three readings were taken and the results were tabulated (n = 3)
Hardness test
Prepared tablets were evaluated for their hardness by using
Monsanto hardness tester. The hardness was measured in terms of kg/cm 2 . Triplicate readings were taken and average was determined.
Friability test
Roche friabilator was used for testing the friability of the tablets.
For this test, 20 tablets were weighted accurately and placed in the friabilator chamber and rotated at 25 rpm for a period of 4 min.
Tablets were again weighted and the percentage weight loss was determining by using formula given below. 
Drug content
Three tablets were weighed and ground in a mortar with pestle to get fine powder. Powder equivalent to the mass of one tablet was dissolved in pH 6.8 phosphate. This solution was diluted with pH 6.8 phosphate buffer. The absorbance of diluted sample of Tolperisone was measured at 260 nm in UV-Visible Spectrophotometer and drug content was calculated using equation obtained from a standard calibration curve.
Wetting time
A piece of tissue paper folded twice was placed in a small Petri dish containing 6 ml of purified water, then a tablet was placed on the paper and the time required for complete wetting was measured.
Wetting time corresponds to the time taken for the tablet to disintegrate when placed gently on the tissue paper in a Petridish.
Less wetting time indicates more porous tablets. 
Water absorption ratio
A piece of tissue paper folded twice was placed in a small petri plate containing 6 ml of distilled water. A tablet was put on the paper and time required for complete wetting was measured. The wetted tablet was then weighed. Water absorption ratio R was calculated using equation. R = 100 {(Wa -Wb)/Wb} Wa = weight of the tablet after water absorption
Where, Wb = weight of the tablet before water absorption
In-vitro disintegration time
The 
In-vitro drug release study
In vitro release study was performed using tablet dissolution test apparatus USP XXIII, apparatus I. The dissolution medium consists of 900 mL phosphate buffer pH6.8 maintained at 37 ± 1°C rotated at 50 rpm. At different interval of time 10 mL sample was withdrawn and replaced with fresh medium. 10 mL sample was diluted to 100 mL phosphate buffer pH 6.8, the aliquots were assayed spectrophotometrically at 260 nm for Tolperisone.
Results and Discussion
Evaluation of pre-compression characteristics of powder blend
The powders were evaluated for bulk density, tapped density, Table 2 ).
The tablet dimension includes diameter and thickness of tablets.
Thickness of all formulations was found to be between 3.21 to 3.62 ( Friability of all the formulation showed % friability less than 1% that indicates ability of tablets to withstand shocks, which may encountered. The data of uniformity of content which was performed by UV spectroscopy indicated that tablets of all batches had drug content within USP limits i.e. between 97.61 to 99.25 %.
In guidance of industrial scientist different parameter of tablet like flow property, dimension hardness, drug content etc. were studied which results in successful trials.
The wetting time and water absorption ratio were found to be 17.79
to 35.07 seconds and 39.24 to 73.38 seconds (Table 4) , respectively. The disintegration time of mouth dissolving tablets ranges from 38.21 to 22.36 seconds (Table 4) .
From above result it has been observed that T7 formulation exhibited excellent wetting time, water absorption ratio and disintegration time as compared to other formulations. Moreover the T8 formulation exhibited lowest wetting time and disintegration time; and highest water absorption ratio. This parameter enhances due to gelling and its subsequent viscosity producing effects. Figure 1 displayed in-vitro dissolution of tablets, it revealed that 78 to 100% of drug release from various formulations. The 50% of the drug was released from the T7 and T8 within 4 minutes. The rapid drug dissolution might be due to easy breakdown of particle by superdisintegrant action. From in vitro dissolution data, it was observed that 98.16% of Tolperisone released in 14 minutes
In vitro drug release studies
indicates that the tablet complies as per IP specifications, that is, 85%-110%. The dissolution rate was found to increase linearly with increase in the concentration of superdisintegrant. Mechanism it followed was wicking and swelling with minimum gelling. It was observed that T8 formulation released 65.62% drug in 12 minutes.
This formulation has maximum amount of superdisintegrant that may cause tablets fragile. Parameters  T1  T2  T3  T4  T5  T6  T7 Ingredients  T1  T2  T3  T4  T5  T6  T7  T8   Tolperisone  150  150  150  150  150  150  150 Value shown in tables is mean of three determinations 
